abstract |
The compound represented by the general formula (I) or (II) (wherein R 1 , R 2 , B and V are as defined in the present specification) is a hepatitis C virus NS5B polymerase inhibitor. Also disclosed are compositions and methods for treating HCV infection and inhibiting HCV replication. |